Investors Urged to Step Forward in Ibotta Class Action Lawsuit Over IPO Allegations

SAN DIEGO — Investors who purchased shares of Ibotta, Inc. (NYSE: IBTA) during its initial public offering last year have the opportunity to take legal action. The law firm Robbins Geller Rudman & Dowd LLP announced that individuals who acquired Ibotta’s publicly traded securities in connection to the company’s IPO held on April 18, 2024, can seek to be appointed as the lead plaintiff in a class action lawsuit. The deadline for filing is June 16, 2025. The suit, known as Fortune v. Ibotta, Inc., No. 25-cv-01213 (D. Colo.), claims that Ibotta, its executives, and … Read more

Legal Action Looms: Ibotta Investors Urged to Join Class Action Lawsuit Over Alleged IPO Misrepresentation

SAN DIEGO — A law firm is urging investors in Ibotta, Inc., to take action following a significant class action lawsuit linked to the company’s recent initial public offering. Robbins Geller Rudman & Dowd LLP has announced that those who purchased Ibotta shares between its registration statement and the prospectus related to its IPO, which occurred around April 18, 2024, have until June 16, 2025, to become the lead plaintiff in a lawsuit against the company. The case, titled Fortune v. Ibotta, Inc., alleges that Ibotta, along with some of its top executives and IPO … Read more

Fraudulent Claims in Class Actions Plummet by Over 40% in Historic Shift, Reveals 2025 Digital Claims Report

Phoenix, Arizona – A significant decrease in claims showing signs of fraud has been reported in class action and mass tort lawsuits for 2024, according to the latest findings from the Annual Report on Digital Claims released by Western Alliance Bank and its subsidiary, Digital Disbursements. The report indicates that claims flagged for substantial fraud indicators dropped over 40%, plummeting from nearly 81 million in 2023 to approximately 48.3 million in 2024. This marked decline represents a notable first in the annual assessments conducted by Western Alliance Bank, particularly following a staggering 19,000% surge in … Read more

Investors File Class Action Lawsuit Against Sana Biotechnology Over Alleged Securities Violations

NEW YORK — Bronstein, Gewirtz & Grossman, LLC, a law firm with national recognition, has announced the filing of a class action lawsuit against Sana Biotechnology, Inc. and specific officers within the company. The litigation targets alleged violations of federal securities laws, focusing on the period between March 17, 2023, and November 4, 2024. The lawsuit accuses Sana, a company listed on NASDAQ under the stock symbol SANA, of disseminating materially false and misleading statements about its business operations and financial health. The core of the allegations lies in the assertion that Sana misled investors … Read more